retatrutide trial results news today This is exciting. 👀 The TRIUMPH-4 for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far beyond Eli Lilly retatrutide Phase 3

Many people wonder about this after seeing ads for these products

Prescribing information (Amneal Pharmaceuticals, 2025)

Disruption of the intestinal barrier is not only a structural issue but also a signaling problem that alters immune tone and metabolic responsiveness

A recent survey conducted in late May of this year shows that just 34% of United States employer health plans offer coverage of GLP-1 drugs for both diabetes management and weight loss

Glucagon-like peptide-1 (GLP-1) is a glucoregulatory hormone synthetized in the intestines and the brain, involved in the maintenance of energy homeostasis mainly by stimulating insulin secretion and regulation of appetite

L.HolstJ